Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 02, 2022

SELL
$22.17 - $51.8 $76,907 - $179,694
-3,469 Reduced 24.64%
10,608 $548,000
Q2 2022

Aug 01, 2022

BUY
$15.36 - $27.51 $15,068 - $26,987
981 Added 7.49%
14,077 $349,000
Q1 2022

May 04, 2022

BUY
$22.22 - $39.12 $141,585 - $249,272
6,372 Added 94.77%
13,096 $242,000
Q4 2021

Feb 07, 2022

BUY
$18.38 - $40.5 $123,587 - $272,322
6,724 New
6,724 $245,000
Q2 2021

Aug 03, 2021

SELL
$9.59 - $50.88 $99,659 - $528,744
-10,392 Closed
0 $0
Q1 2021

May 04, 2021

SELL
$49.53 - $68.4 $184,697 - $255,063
-3,729 Reduced 26.41%
10,392 $532,000
Q4 2020

Feb 01, 2021

BUY
$47.25 - $65.16 $30,665 - $42,288
649 Added 4.82%
14,121 $874,000
Q3 2020

Nov 09, 2020

BUY
$46.35 - $61.69 $37,265 - $49,598
804 Added 6.35%
13,472 $738,000
Q2 2020

Aug 07, 2020

BUY
$38.58 - $65.07 $165,392 - $278,955
4,287 Added 51.15%
12,668 $729,000
Q1 2020

May 04, 2020

SELL
$32.73 - $50.78 $50,175 - $77,845
-1,533 Reduced 15.46%
8,381 $337,000
Q4 2019

Feb 06, 2020

BUY
$6.81 - $39.55 $26,027 - $151,160
3,822 Added 62.74%
9,914 $392,000
Q4 2019

Feb 04, 2020

SELL
$6.81 - $39.55 $4,780 - $27,764
-702 Reduced 10.33%
6,092 $258,000
Q3 2019

Nov 12, 2019

BUY
$6.47 - $8.96 $43,957 - $60,874
6,794 New
6,794 $46,000

Others Institutions Holding CCXI

About ChemoCentryx, Inc.


  • Ticker CCXI
  • Exchange NASDAQ
  • Shares Outstandng 71,919,696
  • Market Cap $3.68M
  • Description
  • ChemoCentryx, Inc., a biopharmaceutical company, focuses on the development and commercialization of new medications for inflammatory disorders, autoimmune diseases, and cancer in the United States. It offers TAVNEOS (avacopan), an orally administered selective C5aR inhibitor for the treatment of adult patients with severe active anti-neutrophil...
More about CCXI
Track This Portfolio

Track Victory Capital Management Inc Portfolio

Follow Victory Capital Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Victory Capital Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Victory Capital Management Inc with notifications on news.